{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:47:34Z","timestamp":1785235654010,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400019"],"award-info":[{"award-number":["81400019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Science and Technology Commission Foundation of Shanghai Pudong New Area","award":["PKJ2013-Y65"],"award-info":[{"award-number":["PKJ2013-Y65"]}]},{"name":"the Shanghai Science and Technology Commission Biomedicine Department key Science and Technology Projects","award":["16411950800"],"award-info":[{"award-number":["16411950800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Primary immunodeficiency disease (PID) is a disorder caused by an inherited flaw in the immune system that increases the susceptibility to infections.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, 112 children with PID were diagnosed and classified based on the 2017 criteria presented by the International Union of Immunological Societies (IUIC) in a single tertiary care center from January 2013 to November 2018. We retrospectively studied the clinical features of those PID children and followed-up them as well.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>It was revealed that male\/female ratio was 6:1. The most frequent diagnosed PID was severe combined immunodeficiency (SCID) (28.6%) and hyper-IgM (HIGM) syndrome (24.1%), followed by predominantly antibody deficiencies (17.8%). Combined immunodeficiencies with associated or syndromic features (12.5%) and congenital defects of phagocyte number, function, or both (10.7%) were less common in our center compared with SCID and HIGM syndrome. Besides, we found that 20 children (17.8%) had a positive family history of PID, and almost all cases (97.3%) had a history of recurrent infection. Recurrent respiratory tract infection was among the most common symptoms, followed by the bacterial infection of the skin and mucous membranes and diarrhea. Additionally, adverse event following immunization (AEFI) was found in 20.5% of the patients, and immune disorder was commonly observed in PID patients. In the present study, 47 patients underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT), and 2-year overall survival (OS) rate for these patients was 78.7% (37\/47). It is noteworthy that OS widely differed among PID patients with different phenotypes who underwent allo-HSCT. The 2-year OS rate for SCID, HIGM syndrome, and the remaining of PID patients who underwent allo-HSCT was 14.3, 83.3, and 100%, respectively.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PID typically emerges at early age. Recurrent infection and serious infection were the most common clinical manifestations. Allo-HSCT is a relatively effective therapeutic strategy for PID patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-019-1729-7","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T13:03:24Z","timestamp":1572872604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center"],"prefix":"10.1186","volume":"19","author":[{"given":"Jinhong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"1729_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","volume":"38","author":"C Picard","year":"2018","unstructured":"Picard C, Bobby Gaspar H, Al-Herz W, et al. International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38:96\u2013128.","journal-title":"J Clin Immunol"},{"issue":"10","key":"1729_CR2","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/INF.0b013e31829aa9e9","volume":"32","author":"ZY Zhang","year":"2013","unstructured":"Zhang ZY, An YF, Jiang LP, Liu W, Liu DW, Xie JW, Tang XM, Wang M, Yang XQ, Zhao XD. Distribution, clinical features and molecular analysis of primary immunodeficiency diseases in Chinese children: a single-center study from 2005 to 2011. Pediatr Infect Dis J. 2013;32(10):1127\u201334.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"1729_CR3","first-page":"302","volume":"23","author":"H Zeng","year":"2013","unstructured":"Zeng H, Tao Y, Chen X, et al. Primary immunodeficiency in South China: clinical features and a genetic subanalysis of 138 children. J Investig Allergol Clin Immunol. 2013;23(5):302\u20138.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"1729_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","volume":"38","author":"A Bousfiha","year":"2018","unstructured":"Bousfiha A, Jeddane L, Picard C, et al. The 2017 IUIS phenotypic classification for primary Immunodeficiencies. J Clin Immunol. 2018;38:129\u201343.","journal-title":"J Clin Immunol"},{"key":"1729_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","volume":"35","author":"C Picard","year":"2015","unstructured":"Picard C, Al-Herz W, Bousfiha A, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35:696\u2013726.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1729_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2249.2011.04542.x","volume":"167","author":"B Gathmann","year":"2012","unstructured":"Gathmann B, Binder N, Ehl S, et al. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012;167(3):479\u201391.","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"1729_CR7","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s10875-014-0102-8","volume":"34","author":"L Kobrynski","year":"2014","unstructured":"Kobrynski L, Powell RW, Bowen S. Prevalence and Morbidity of Primary Immunodeficiency Diseases, United States 2001\u20132007. J Clin Immunol. 2014 Nov;34(8):954\u201361.","journal-title":"J Clin Immunol"},{"issue":"5","key":"1729_CR8","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.jaip.2017.12.002","volume":"6","author":"Z Rubin","year":"2018","unstructured":"Rubin Z, Pappalardo A, Schwartz A, Antoon JW. Prevalence and Outcomes of Primary Immunodeficiency in Hospitalized Children in the United States. J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1705\u201310.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1729_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s12026-016-8784-z","volume":"64","author":"V Modell","year":"2016","unstructured":"Modell V, Quinn J, Orange J, Notarangelo LD, Modell F. Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell centers global network. Immunol Res. 2016;64:736\u201353.","journal-title":"Immunol Res"},{"issue":"3","key":"1729_CR10","first-page":"122","volume":"49","author":"M Reisi","year":"2017","unstructured":"Reisi M, Azizi G, Kiaee F, et al. Evaluation of pulmonary complications in patients with primary immunodeficiency disorders. Eur Ann Allergy Clin Immunol. 2017;49(3):122\u20138.","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"1729_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jpeds.2017.10.029","volume":"194","author":"V Barlogis","year":"2018","unstructured":"Barlogis V, Mahlaoui N, Auquier P, et al. Burden of poor health conditions and quality of life in 656 children with primary immunodeficiency. J Pediatr. 2018;194:211\u20137.","journal-title":"J Pediatr"},{"key":"1729_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.cgh.2013.02.024","volume":"11","author":"S Agarwal","year":"2013","unstructured":"Agarwal S, Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol. 2013;11:1050\u201363.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1729_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10875-017-0461-z","volume":"38","author":"A Pecoraro","year":"2018","unstructured":"Pecoraro A, Nappi L, Crescenzi L, D\u2019Armiento FP, Genovese A, Spadaro G. Chronic diarrhea in common variable immunodeficiency: a case series and review of the literature. J Clin Immunol. 2018;38:67\u201376.","journal-title":"J Clin Immunol"},{"key":"1729_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/pai.12814","volume":"28","author":"G Angelino","year":"2017","unstructured":"Angelino G, De Angelis P, Faraci S, et al. Inflammatory bowel disease in chronic granulomatous disease: an emerging problem over a twenty years' experience. Pediatr Allergy Immunol. 2017;28:801\u20139.","journal-title":"Pediatr Allergy Immunol"},{"key":"1729_CR15","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","volume":"141","author":"F Barzaghi","year":"2018","unstructured":"Barzaghi F, Amaya Hernandez LC, Neven B, et al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study. J Allergy Clin Immunol. 2018;141:1036\u201349.","journal-title":"J Allergy Clin Immunol"},{"key":"1729_CR16","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.vaccine.2016.01.047","volume":"34","author":"JD Sarmiento","year":"2016","unstructured":"Sarmiento JD, Villada F, Orrego JC, Franco JL, Trujillo-Vargas CM. Adverse events following immunization in patients with primary immunodeficiencies. Vaccine. 2016;34:1611\u20136.","journal-title":"Vaccine."},{"key":"1729_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jaci.2017.12.980","volume":"141","author":"FA Bonilla","year":"2018","unstructured":"Bonilla FA. Update: vaccines in primary immunodeficiency. J Allergy Clin Immunol. 2018;141:474\u201381.","journal-title":"J Allergy Clin Immunol"},{"key":"1729_CR18","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","volume":"133","author":"BE Marciano","year":"2014","unstructured":"Marciano BE, Huang CY, Joshi G, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133:1134\u201341.","journal-title":"J Allergy Clin Immunol"},{"key":"1729_CR19","first-page":"543","volume":"64","author":"S Norouzi","year":"2012","unstructured":"Norouzi S, Aghamohammadi A, Mamishi S, Rosenzweig SD, Rezaei N. Bacillus Calmette-Gu\u00e9rin (BCG) complications associated with primary immunodeficiency diseases. J Inf Secur. 2012;64:543\u201354.","journal-title":"J Inf Secur"},{"key":"1729_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13104-017-2499-7","volume":"10","author":"S Al-Hammadi","year":"2017","unstructured":"Al-Hammadi S, Alsuwaidi AR, Alshamsi ET, Ghatasheh GA, Souid AK. Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infections in infants with immunodeficiency. BMC Res Notes. 2017;10:177.","journal-title":"BMC Res Notes"},{"key":"1729_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrrheum.2017.198","volume":"14","author":"RE Schmidt","year":"2017","unstructured":"Schmidt RE, Grimbacher B, Witte T. Autoimmunity and primary immunodeficiency: two sides of the same coin? Nat Rev Rheumatol. 2017;14:7\u201318.","journal-title":"Nat Rev Rheumatol"},{"key":"1729_CR22","doi-asserted-by":"crossref","unstructured":"Susheela AT, Hale A. Patients with common variable immunodeficiency paradoxically have increased rates of autoimmune disorders. BMJ Case Rep. 2017.","DOI":"10.1136\/bcr-2017-221657"},{"key":"1729_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/1744666X.2017.1384312","volume":"13","author":"G Azizi","year":"2017","unstructured":"Azizi G, Tavakol M, Rafiemanesh H, et al. Autoimmunity in a cohort of 471 patients with primary antibody deficiencies. Expert Rev Clin Immunol. 2017;13:1099\u2013106.","journal-title":"Expert Rev Clin Immunol"},{"key":"1729_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13023-016-0452-9","volume":"11","author":"B Bienvenu","year":"2016","unstructured":"Bienvenu B, Cozon G, Hoarau C, et al. Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort \u201cVisages.\u201d. Orphanet J Rare Dis. 2016;11:83.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1729_CR25","first-page":"76","volume":"6","author":"G Krivan","year":"2017","unstructured":"Krivan G, Jolles S, Granados EL, et al. New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients. Am J Clin Exp Immunol. 2017;6(5):76\u201383.","journal-title":"Am J Clin Exp Immunol"},{"key":"1729_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/1744666X.2018.1424627","volume":"14","author":"MA Slatter","year":"2018","unstructured":"Slatter MA, Gennery AR. Hematopoietic cell transplantation in primary immunedeficienc \u2013y-conventional and emerging indications. Expert Rev Clin Immunol. 2018;14:103\u201314.","journal-title":"Expert Rev Clin Immunol"},{"key":"1729_CR27","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1182\/blood-2017-09-807487","volume":"131","author":"TA Fox","year":"2018","unstructured":"Fox TA, Chakraverty R, Burns S, et al. Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency. Blood. 2018;131:917\u201331.","journal-title":"Blood."},{"key":"1729_CR28","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","volume":"130","author":"J Heimall","year":"2017","unstructured":"Heimall J, Logan BR, Cowan MJ, et al. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017;130:2718\u201327.","journal-title":"Blood."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1729-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1729-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1729-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:24:25Z","timestamp":1604363065000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1729-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1729"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1729-7","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"24 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of the Shanghai Children\u2019s Medical Center Affiliated to Shanghai Jiaotong University School of Medicine approved the study, and each patient provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"410"}}